<DOC>
	<DOCNO>NCT00200382</DOCNO>
	<brief_summary>The purpose study develop new treatment hopefully result relief symptom prolongation life . For reason , doctor offer treatment new experimental drug call PS 341 .</brief_summary>
	<brief_title>Phase II Study Therapy With PS 341 Patients With Advanced Stage Non Small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Bortezomib</mesh_term>
	<criteria>Patients must confirm NSCLC ( squamous , adeno large cell anaplastic carcinoma ) stage III B Stage IV . No prior chemotherapy regimen Patients must adequate organ marrow function Untreated symptomatic brain metastasis Patients know HIV positivity</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
</DOC>